NCT01229085

Efficacy Study of the Combination Mometasone + Salicylic Acid in Patients With Psoriasis

CLINICAL ASSESSMENT OF THE EFFECTIVENESS OF ASSOCIATION MONETASONE FUROATE 0.1% SALICYLIC ACID AND 5% FOR SUBMISSION OF OINTMENT TOPICAL DERMATOLOGICAL USE OF LABORATORY Glenmark Pharmaceuticals Ltd, IN PATIENTS WITH PSORIASIS.

• Status: Completed
• Phase: Phase 3
• Study type: Interventional
• Enrollment: 71 (actual)
• Sponsor: Azidus Brasil · Industry
• Sex: All
• Age: 18 Years – 70 Years
• Healthy volunteers: Not accepted

Summary

To evaluate the efficacy of the combination of mometasone furoate 0.1% and Salicylic Acid 5% in patients of both sexes who presented clinical symptoms of psoriasis of mild to moderate.

Detailed description

Phase III clinical trial, systematic sampling, open-label study that evaluated the efficacy of the combination of mometasone furoate 0.1% and 5% salicylic acid in 71 patients with lesions of mild to moderate psoriasis treated for up to 45 days or less than this, at the discretion of the investigator. The results were statistically analyzed and investigational data and their conclusions are referred to in this report.

Conditions

• Psoriasis

Interventions

Type	Name	Description
DRUG	memotasone + salicylic acid	mometasone 0,1% + salicylic acid 5%.

Timeline

• Start date: 2006-09-01
• Primary completion: 2007-10-01
• Completion: 2007-10-01
• First posted: 2010-10-27
• Last updated: 2010-10-27

Locations

1 site across 1 country: Brazil